A carregar...
IMMU-63. OVERCOMING GLIOBLASTOMA RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE VIA RNA-LOADED NANOPARTICLES
BACKGROUND: In a randomized phase III study for recurrent glioblastoma (GBM), checkpoint inhibition with nivolumab failed to improve overall survival outcomes. GBM immune escape through loss of MHC class expression juxtaposed to an immunoregulatory milieu, both local and systemic, remain significant...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692051/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.520 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|